Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Sees Large Drop in Short Interest

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) saw a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 1,050,000 shares, a drop of 15.3% from the March 31st total of 1,240,000 shares. Currently, 2.4% of the shares of the company are sold short. Based […]

Leave a Reply

Your email address will not be published.

Previous post Absci Co. (NASDAQ:ABSI) Short Interest Update
Next post ACM Research, Inc. (NASDAQ:ACMR) Short Interest Up 12.2% in April